Roshawn A. Blunt - 02 Aug 2022 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Director
Signature
/s/ Jennifer Lam, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
02 Aug 2022
Net transactions value
$0
Form type
3
Filing time
02 Aug 2022, 19:08:46 UTC
Previous filing
29 Jun 2022
Next filing
08 Jun 2023

No securities are beneficially owned.